196 related articles for article (PubMed ID: 22695718)
1. Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249.
Stolarczyk EI; Reiling CJ; Pickin KA; Coppage R; Knecht MR; Paumi CM
Mol Pharmacol; 2012 Sep; 82(3):488-99. PubMed ID: 22695718
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Ycf1p function by Cka1p-dependent phosphorylation is attenuated in response to salt stress.
Pickin KA; Ezenwajiaku N; Overcash H; Sethi M; Knecht MR; Paumi CM
FEMS Yeast Res; 2010 Nov; 10(7):839-57. PubMed ID: 20812950
[TBL] [Abstract][Full Text] [Related]
3. Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma.
Zhou B; Ritt DA; Morrison DK; Der CJ; Cox AD
J Biol Chem; 2016 Aug; 291(34):17804-15. PubMed ID: 27226552
[TBL] [Abstract][Full Text] [Related]
4. A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance.
Conrad S; Kauffmann HM; Ito K; Leslie EM; Deeley RG; Schrenk D; Cole SP
Pharmacogenetics; 2002 Jun; 12(4):321-30. PubMed ID: 12042670
[TBL] [Abstract][Full Text] [Related]
5. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of polar amino acid residues within predicted transmembrane helices 10 and 16 of multidrug resistance protein 1 (ABCC1): effect on substrate specificity.
Zhang DW; Nunoya K; Vasa M; Gu HM; Cole SP; Deeley RG
Drug Metab Dispos; 2006 Apr; 34(4):539-46. PubMed ID: 16415113
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.
Di Maira G; Brustolon F; Bertacchini J; Tosoni K; Marmiroli S; Pinna LA; Ruzzene M
Oncogene; 2007 Oct; 26(48):6915-26. PubMed ID: 17486073
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase CK2 regulates cytoskeletal reorganization during ionizing radiation-induced senescence of human mesenchymal stem cells.
Wang D; Jang DJ
Cancer Res; 2009 Oct; 69(20):8200-7. PubMed ID: 19826041
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
Grant CE; Gao M; DeGorter MK; Cole SP; Deeley RG
Drug Metab Dispos; 2008 Dec; 36(12):2571-81. PubMed ID: 18775981
[TBL] [Abstract][Full Text] [Related]
10. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G
Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897
[TBL] [Abstract][Full Text] [Related]
11. Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1).
Leslie EM; Létourneau IJ; Deeley RG; Cole SP
Biochemistry; 2003 May; 42(18):5214-24. PubMed ID: 12731862
[TBL] [Abstract][Full Text] [Related]
12. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
13. Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.
Xu WF; Ma YC; Ma HS; Shi L; Mu H; Ou WB; Peng J; Li TT; Qin T; Zhou HM; Fu XQ; Li XH
Cell Cycle; 2019 Dec; 18(24):3472-3490. PubMed ID: 31713447
[TBL] [Abstract][Full Text] [Related]
14. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
Li X; Guan B; Maghami S; Bieberich CJ
Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided probing of the leukotriene C
Conseil G; Arama-Chayoth M; Tsfadia Y; Cole SPC
FASEB J; 2019 Oct; 33(10):10692-10704. PubMed ID: 31268744
[TBL] [Abstract][Full Text] [Related]
16. Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines.
Zhang DW; Cole SP; Deeley RG
J Biol Chem; 2001 Apr; 276(16):13231-9. PubMed ID: 11278596
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.
Wang J; Feng C; He Y; Ding W; Sheng J; Arshad M; Zhang X; Li P
Oncotarget; 2015 Sep; 6(29):27700-13. PubMed ID: 26172393
[TBL] [Abstract][Full Text] [Related]
18. Determinants of the substrate specificity of multidrug resistance protein 1: role of amino acid residues with hydrogen bonding potential in predicted transmembrane helix 17.
Zhang DW; Cole SP; Deeley RG
J Biol Chem; 2002 Jun; 277(23):20934-41. PubMed ID: 11925441
[TBL] [Abstract][Full Text] [Related]
19. The intracellular domain of L1CAM binds to casein kinase 2α and is neuroprotective via inhibition of the tumor suppressors PTEN and p53.
Wang Y; Schachner M
J Neurochem; 2015 Jun; 133(6):828-43. PubMed ID: 25727698
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function.
Létourneau IJ; Slot AJ; Deeley RG; Cole SP
Drug Metab Dispos; 2007 Aug; 35(8):1372-9. PubMed ID: 17494643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
